Safety and Tolerability of the Novel Inhaled Corticosteroid Fluticasone Furoate in Combination With the Β2agonist Vilanterol Administered Once Daily for 52 Weeks in Patients ≥12 Years Old With Asthma: A Randomised Trial
Thorax - United Kingdom
doi 10.1136/thoraxjnl-2012-202606
Full Text
Open PDFAbstract
Available in full text
Date
February 25, 2013
Authors
Publisher
BMJ